The incidence and survival rates of colorectal cancer in india remain low compared with rising rates in east Asia

Diseases of the Colon and Rectum

Volumn 55, Issue 8, 2012, Pages 900-906

  Pathy, Sushmita ^a   Lambert, René ^b   Sauvaget, Catherine ^b   Sankaranarayanan, Rengaswamy ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Cancer; Colorectal cancer; Incidence; India; Mortality; Survival

Indexed keywords

ARTICLE; AWARENESS; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; COLORECTAL CANCER; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; ECOLOGY; ENVIRONMENTAL FACTOR; FEMALE; FOOD INTAKE; HUMAN; INDIA; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; SUGAR INTAKE; SURVIVAL RATE;

EID: 84866261829     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0b013e31825afc4e     Document Type: Article

References (37)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available at: http://globocan.iarc.fr. Accessed January 27, 2012.
2. Curado MP, Edwards B, Shin HR, et al, eds. Cancer Incidence in Five Continents. Vol IX. IARC Scientific Publications No. 160. Lyon, France: International Agency for Research on Cancer; 2007.
3. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, eds. Cancer Incidence in Five Continents. Vol VIII. IARC Scientific Publications No. 155. Lyon, France: International Agency for Research on Cancer; 2002.
4. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, eds. Cancer Incidence in Five Continents. Vol VII. IARC Scientific Publications No. 143. Lyon, France: International Agency for Research on Cancer; 1997.
5. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J, eds. Cancer Incidence in Five Continents. Vol VI. IARC Scientific Publications No. 120. Lyon, France: International Agency for Research on Cancer; 1992.
6. Muir CS, Waterhouse J, Mack T, Powell J, Whelan SL, eds. Cancer Incidence in Five Continents. Vol V. IARC Scientific Publications No. 88. Lyon, France: International Agency for Research on Cancer; 1987.
7. Waterhouse J, Muir CS, Shanmugaratnam K, Powell J, eds. Cancer Incidence in Five Continents. Vol IV. IARC Scientific Publications No. 42. Lyon, France: International Agency for Research on Cancer; 1982.
8. Waterhouse J, Muir CS, Correa P, Powell J, eds. Cancer Incidence in Five Continents. Vol III. IARC Scientific Publications No. 15. Lyon, France: International Agency for Research on Cancer; 1976.
9. Doll R, Muir CS, Waterhouse JAH, eds. Cancer Incidence in Five Continents. Vol II. Geneva, Switzerland: Union Internationale Contre le Cancer; 1970.
10. World Health Organization, Mortality database. Available at: http://www.who.int/whosis/mort/download/en/index. Accessed January 27, 2012.
11. Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin. 2009;59:366-378.
12. Surveillance Epidemiology and End Results (SEER). Program public use (1973-1997). National Cancer Institute. Available at: http://seer.cancer.gov/ registreis/. Accessed January 27, 2012.
13. Sankaranarayanan R, Black RJ, Parkin DM, eds. Cancer Survival in Developing Countries. IARC Scientific Publications No. 145. Lyon, France: International Agency for Research on Cancer; 1988.
14. Sankaranarayanan R, Swaminathan R, eds. Cancer Survival in Africa, Asia, the Caribbean and Central America (SurvCan). IARC Scientific Publications No. 162. Lyon, France: International Agency for Research on Cancer; 2011.
15. Reis LA, Young JL, Keel GE, Eisner MP, Lin YD, Hornor MJ, eds. Cancer Survival Among Adults: US SEER Program, 1988-2001, Patient and Tumor Characteristics. SEER Survival Monograph. National Cancer institute, SEER Program, NIH Publication No. 07-6215. Bethesda, MD National Cancer institute; 2007.
16. Gloeckler Ries LA, Reichman ME, Lewis DR, Hankey BF, Edwards BK. Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist. 2003;8:541-552.
17. Coleman MP, Quaresma M, Berrino F, et al.; CONCORD Working Group. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008;9:730-756.
18. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R; EUROCARE Working Group. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer. 2009;45:931-991.
19. De Angelis R, Francisci S, Baili P, et al.; EUROCARE Working Group. The EUROCARE-4 database on cancer survival in Europe: data standardisation, quality control and methods of statistical analysis. Eur J Cancer. 2009;45:909-930.
20. Berrino F, De Angelis R, Sant M, et al.; EUROCARE Working group. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol. 2007;8:773-783.
21. Verdecchia A, Francisci S, Brenner H, et al.; EUROCARE-4 Working Group. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol. 2007;8:784-796.
22. Matsuda T, Ajiki W, Marugame T, Ioka A, Tsukuma H, Sobue T; Research Group of Population-Based Cancer Registries of Japan. Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study. Jpn J Clin Oncol. 2011;41:40-51.
23. Toyoda Y, Nakayama T, Ito Y, Ioka A, Tsukuma H. Trends in colorectal cancer incidence by subsite in Osaka, Japan. Jpn J Clin Oncol. 2009;39:189-191.
24. Parkin DM, Boyd L, Walker LC. The Fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer. 2011;105(suppl 2):S77-S81.
25. World Cancer Research Fund/American Institute for Cancer Research (AICR). Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. AICR: Washington, DC; 2007.
26. Mohandas KM. Colorectal cancer in India: controversies, enigmas and primary prevention. Indian J Gastroenterol. 2011;30:3-6.
27. Nayak SP, Sasi MP, Sreejayan MP, Mandal S. A case-control study of roles of diet in colorectal carcinoma in a South Indian Population. Asian Pac J Cancer Prev. 2009;10:565-568.
28. Sullivan R, Kinra S, Ekelund U, et al. Socio-demographic patterning of physical activity across migrant groups in India: results from the Indian Migration Study. PLoS ONE. 2011;6:e24898.
29. Lund Nilsen TI, Vatten LJ. Colorectal cancer associated with BMI, physical activity, diabetes, and blood glucose. IARC Sci Publ. 2002;156:257-258.
30. Boffetta P, Couto E, Wichmann J, et al. Fruit and vegetable intake and overall cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2010;102:529-537.
31. van Duijnhoven FJ, Bueno-De-Mesquita HB, Ferrari P, et al. Fruit, vegetables, and colorectal cancer risk: the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr. 2009;89:1441-1452.
32. García-Alvarez A, Serra-Majem L, Ribas-Barba L, et al. Obesity and overweight trends in Catalonia, Spain (1992-2003): gender and socio-economic determinants. Public Health Nutr. 2007;10(11A):1368-1378.
33. Martín JJ, Hernández LS, Gonzalez MG, Mendez CP, Rey Galán C, Guerrero SM. Trends in childhood and adolescent obesity prevalence in Oviedo (Asturias, Spain) 1992-2006. Acta Paediatr. 2008;97:955-958.
34. Davies NJ, Batehup L, Thomas R. The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature. Br J Cancer. 2011;105 Suppl 1: S52-S73.
35. Wolin KY, Yan Y, Colditz GA, Lee IM. Physical activity and colon cancer prevention: a meta-analysis. Br J Cancer. 2009;100:611-616.
36. Yeole BB, Sunny L, Swaminathan R, Sankaranarayanan R, Parkin DM. Population-based survival from colorectal cancer in Mumbai, (Bombay) India. Eur J Cancer. 2001;37:1402-1408.
37. Lambert R, Sauvaget C, Sankaranarayanan R. Mass screening for colorectal cancer is not justified in most developing countries. Int J Cancer. 2009;125:253-256.